| CAF in metastatic breast cancer: standard therapy or another effective regimen? |
| DF Hayes and IC Henderson |
|
JCO Oct 1 1987: 1497–1499.
[PDF]
|
 |
| Adjuvant irradiation following mastectomy: where are we? |
| HB Muss |
|
JCO Oct 1 1987: 1500–1501.
[PDF]
|
 |
| Karnofsky memorial lecture. An odyssey in the land of small tumors |
| CG Moertel |
|
JCO Oct 1 1987: 1502–1522.
[PDF]
|
 |
|
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B |
| |
J Aisner, V Weinberg, M Perloff, R Weiss, M Perry, A Korzun, S Ginsberg, and JF Holland |
| |
JCO Oct 1 1987: 1523–1533.
[Abstract]
[PDF]
|
 |
|
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081 |
| |
MC Perry, CG Kardinal, AH Korzun, SJ Ginsberg, PC Raich, JF Holland, RR Ellison, S Kopel, A Schilling, and J Aisner |
| |
JCO Oct 1 1987: 1534–1545.
[Abstract]
[PDF]
|
 |
|
The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy |
| |
KL Griem, IC Henderson, R Gelman, D Ascoli, B Silver, A Recht, RL Goodman, S Hellman, and JR Harris |
| |
JCO Oct 1 1987: 1546–1555.
[Abstract]
[PDF]
|
 |
|
Tamoxifen rechallenge: response to tamoxifen following relapse after adjuvant chemohormonal therapy for breast cancer |
| |
HB Muss, LR Smith, and MR Cooper |
| |
JCO Oct 1 1987: 1556–1558.
[Abstract]
[PDF]
|
 |
|
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma |
| |
N Petrelli, L Herrera, Y Rustum, P Burke, P Creaven, J Stulc, LJ Emrich, and A Mittelman |
| |
JCO Oct 1 1987: 1559–1565.
[Abstract]
[PDF]
|
 |
|
Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer |
| |
JV Sitzmann, SE Order, JL Klein, PK Leichner, EK Fishman, and GW Smith |
| |
JCO Oct 1 1987: 1566–1573.
[Abstract]
[PDF]
|
 |
|
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer |
| |
JF Bishop, D Raghavan, R Stuart-Harris, G Morstyn, R Aroney, R Kefford, K Yuen, J Lee, P Gianoutsos, and IN Olver |
| |
JCO Oct 1 1987: 1574–1578.
[Abstract]
[PDF]
|
 |
|
Surgery after initial chemotherapy for localized small-cell carcinoma of the lung |
| |
CJ Williams, I McMillan, R Lea, G Mead, J Thompson, J Sweetenham, A Herbert, M Jefferys, R Buchanan, and JM Whitehouse |
| |
JCO Oct 1 1987: 1579–1588.
[Abstract]
[PDF]
|
 |
|
Phase I trial of escalating doses of cisplatin in hypertonic saline |
| |
D Bajorin, GJ Bosl, and R Fein |
| |
JCO Oct 1 1987: 1589–1593.
[Abstract]
[PDF]
|
 |
|
Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer |
| |
I Haines, G Bosl, D Pfister, R Spiro, F Gerold, R Sessions, J Shah, E Strong, B Vikram, and L Harrison |
| |
JCO Oct 1 1987: 1594–1600.
[Abstract]
[PDF]
|
 |
|
Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck |
| |
AA Forastiere, SR Baker, R Wheeler, and BR Medvec |
| |
JCO Oct 1 1987: 1601–1606.
[Abstract]
[PDF]
|
 |
|
Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy |
| |
SB Howell, S Zimm, M Markman, IS Abramson, S Cleary, WE Lucas, and RJ Weiss |
| |
JCO Oct 1 1987: 1607–1612.
[Abstract]
[PDF]
|
 |
|
Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia |
| |
EL Zakris, MW Dewhirst, JE Riviere, PJ Hoopes, RL Page, and JR Oleson |
| |
JCO Oct 1 1987: 1613–1620.
[Abstract]
[PDF]
|
 |
|
Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix |
| |
JJ Kavanagh, D Gershenson, L Copeland, and WS Roberts |
| |
JCO Oct 1 1987: 1621–1623.
[Abstract]
[PDF]
|
 |
|
Major complications and causes of death in patients treated for Hodgkin's disease |
| |
RE van Rijswijk, J Verbeek, C Haanen, AW Dekker, WA van Daal, and HA van Peperzeel |
| |
JCO Oct 1 1987: 1624–1633.
[Abstract]
[PDF]
|
 |
|
Modification of Kiel and working formulation classifications for improved survival prediction in non-Hodgkin's lymphoma |
| |
JM Nabholtz, S Friedman, F Collin, and J Guerrin |
| |
JCO Oct 1 1987: 1634–1639.
[Abstract]
[PDF]
|
 |
|
The effects of distance from primary treatment centers on survival among patients with multiple myeloma |
| |
RE Lenhard, Jr, JP Enterline, J Crowley, and GY Ho |
| |
JCO Oct 1 1987: 1640–1645.
[Abstract]
[PDF]
|
 |
|
Long-term evaluation of a CNS prophylaxis trial--treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group |
| |
JA Ortega, ME Nesbit, HN Sather, LL Robison, GJ D'Angio, and GD Hammond |
| |
JCO Oct 1 1987: 1646–1654.
[Abstract]
[PDF]
|
 |
|
A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis |
| |
RN Hitchins, DR Bell, RL Woods, and JA Levi |
| |
JCO Oct 1 1987: 1655–1662.
[Abstract]
[PDF]
|
 |
|
Comparison of spinal magnetic resonance imaging and myelography in cancer patients |
| |
C Hagenau, W Grosh, M Currie, and RG Wiley |
| |
JCO Oct 1 1987: 1663–1669.
[Abstract]
[PDF]
|
 |
| Reporting outcomes in Hodgkin's disease and lymphoma |
| DO Dixon, P McLaughlin, FB Hagemeister, EJ Freireich, LM Fuller, FF Cabanillas, and EA Gehan |
|
JCO Oct 1 1987: 1670–1672.
[PDF]
|
 |
|
Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus |
| |
AF List, FA Greco, and LB Vogler |
| |
JCO Oct 1 1987: 1673–1689.
[Abstract]
[PDF]
|
 |
|
Flow cytometry, cellular DNA content, and prognosis in human malignancy |
| |
DE Merkel, LG Dressler, and WL McGuire |
| |
JCO Oct 1 1987: 1690–1703.
[Abstract]
[PDF]
|
 |
| Surgical excision in stage I-II small-cell lung cancer |
| KM Sivarajan |
|
JCO Oct 1 1987: 1704a–1705.
[PDF]
|
 |
| Severe life-threatening toxicities observed in study using leucovorin with 5-fluorouracil |
| JL Grem, DD Shoemaker, NJ Petrelli, and HO Douglass, Jr |
|
JCO Oct 1 1987: 1704b.
[PDF]
|
 |
| Treatment of anthracycline extravasation--recommendations for practice |
| KV Harwood |
|
JCO Oct 1 1987: 1705a.
[PDF]
|
 |
| Red hair and hyperpigmentation in a black man after chemotherapy |
| C Loureiro, PS Gill, M Rarick, and AM Levine |
|
JCO Oct 1 1987: 1705b–1706.
[PDF]
|
 |